EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rift Valley fever virus is able to cross the human blood–brain barrier in vitro by direct infection with no deleterious effects

Jordan Quellec iD, Camille Piro-Megy, Marion Cannac, Sébastien Nisole, Florent H Marty, Fabien Gosselet, Fumitaka Shimizu, Takashi Kanda, Catherine Cêtre-Sossah iD, Sara Salinas iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01267-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Jordan Quellec und 9 weiteren Autor:innen. Beteiligte Einrichtung: ASTRE, CIRAD, INRAE, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Rift Valley fever virus, Rift Valley Fever, Astrocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche (ANR), Université de Montpellier (UM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rift Valley fever (RVF) is a zoonotic arboviral disease that causes recurrent epidemics in Africa that may trigger fatal neurological disorders. However, the mechanisms of neuroinvasion by which the RVF virus (RVFV) reaches the human central nervous system (CNS) remain poorly characterized. In particular, it is not clear how RVFV is able to cross the human blood–brain barrier (hBBB), which is a neurovascular endothelium that protects the brain by regulating brain and blood exchanges. To explore these mechanisms, we used an in vitro hBBB model to mimic in vivo hBBB selectiveness and apicobasal polarity. Our results highlight the ability of RVFV to cross the hBBB by direct infection in a non-structural protein S (NSs)-independent but strain-dependent manner, leading to astrocyte and pericyte infections. Interestingly, RVFV infection did not induce hBBB disruption and was associated with progressive elimination of infected cells with no impairment of the tight junction protein scaffold and barrier function. Our work also shows that NSs, a well described RVFV virulence factor, limited the establishment of the hBBB-induced innate immune response and subsequent lymphocyte recruitment. These results provide in vitro confirmation of the ability of RVFV to reach human CNS by direct infection of the hBBB without altering its barrier function, and provide new directions to explore human RVFV neurovirulence and neuroinvasion mechanisms. IMPORTANCE The RVF virus (RVFV) is capable of infecting humans and inducing severe and fatal neurological disorders. Neuropathogenesis and human central nervous system (CNS) invasion mechanisms of RVFV are still unknown, with only historical studies of autopsy data from fatal human cases in the 1980s and exploration studies in rodent models. One of the gaps in understanding RVFV human pathogenesis is how RVFV is able to cross the blood–brain barrier (BBB) in order to reach the human CNS. For the first time, we show that RVFV is able to directly infect cells of the human BBB in vitro to release viral particles into the human CNS, a well-characterized neuroinvasion mechanism of pathogens. Furthermore, we demonstrate strain-dependent variability of this neuroinvasion mechanism, identifying possible viral properties that could be explored to prevent neurological disorders during RVFV outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierRift Valley fever virusRift Valley FeverAstrocytesHumansViral Nonstructural ProteinsPericytesAnimalsCell LineEndothelial CellsBrain

Stichwörter der Autor:innen

Rift Valley fever virusblood brain barrierendothelium integrityimmune responseneuroinvasion

Substanzen

Viral Nonstructural Proteins

Autor:innen und Institutionen

  • ASTRE, CIRAD, INRAE, University of Montpellier, Montpellier, France.
  • PCCEI, University of Montpellier, INSERM, Etablissement Français du Sang, Montpellier, France.
  • IRIM, CNRS UMR9004, University of Montpellier, Montpellier, France.
  • Blood Brain Barrier Laboratory, Faculty of Science Jean Perrin, Artois University, Lens, France.
  • Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

ORCID-Profile: Jordan Quellec, Catherine Cêtre-Sossah, Sara Salinas

Förderung

  • Agence Nationale de la Recherche (ANR)
  • Université de Montpellier (UM)

Zitieren

APA

Quellec, J., Piro-Megy, C., Cannac, M., Nisole, S., Marty, F. H., Gosselet, F., Shimizu, F., Kanda, T., Cêtre-Sossah, C., & Salinas, S. (2024). Rift Valley fever virus is able to cross the human blood–brain barrier in vitro by direct infection with no deleterious effects. Journal of Virology. https://doi.org/10.1128/jvi.01267-24

Vancouver

Quellec J, Piro-Megy C, Cannac M, Nisole S, Marty FH, Gosselet F, et al. Rift Valley fever virus is able to cross the human blood–brain barrier in vitro by direct infection with no deleterious effects. Journal of Virology. 2024. doi:10.1128/jvi.01267-24

BibTeX
@article{Quellec2024,
  author = {Quellec, Jordan and Piro-Megy, Camille and Cannac, Marion and Nisole, Sébastien and Marty, Florent H and Gosselet, Fabien and Shimizu, Fumitaka and Kanda, Takashi and Cêtre-Sossah, Catherine and Salinas, Sara},
  title = {Rift Valley fever virus is able to cross the human blood–brain barrier in vitro by direct infection with no deleterious effects},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01267-24}
}
Kostenlos starten →